Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study Article

Industry Collaboration International Collaboration

cited authors

  • Paz-Ares, Luis; Mezger, Joerg; Ciuleanu, Tudor E.; Fischer, Juergen R.; von Pawel, Joachim; Provencio, Mariano; Kazarnowicz, Andrzej; Losonczy, Gyoergy; de Castro, Gilberto, Jr.; Szczesna, Aleksandra; Crino, Lucio; Reck, Martin; Ramlau, Rodryg; Ulsperger, Ernst; Schumann, Christian; Miziara, Jose Elias A.; Lessa, Alvaro E.; Dediu, Mircea; Balint, Beatrix; Depenbrock, Henrik; Soldatenkova, Victoria; Kurek, Raffael; Hirsch, Fred R.; Thatcher, Nick; Socinski, Mark A.; INSPIRE Investigators

authors

Publication Date

  • March 1, 2015

webpage

published in

category

start page

  • 328

end page

  • 337

volume

  • 16

issue

  • 3